Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacy
Open Access
- 6 February 2025
- journal article
- Published by Elsevier in STAR Protocols
- Vol. 6 (1) , 103623
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL146802)
- National Heart, Lung, and Blood Institute (R43HL156578)
- National Institutes of Health
- Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine
- Tobacco-Related Disease Research Program (T32IR5347)
This publication has 10 references indexed in Scilit:
- Cryopreserved human precision-cut lung slices provide an immune competent pulmonary test system for “on-demand” use and long-term culturesToxicological Sciences, 2023
- Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation systemClinical and Experimental Vaccine Research, 2023
- Precision-Cut Tumor Slices (PCTS) as an Ex Vivo Model in Immunotherapy ResearchAntibodies, 2022
- A pre‑clinical model combining cryopreservation technique with precision‑cut slice culture method to assess the in vitro drug response of hepatocellular carcinomaInternational Journal of Molecular Medicine, 2022
- Protocol for tissue slice cultures from human solid tumors to study therapeutic responseSTAR Protocols, 2021
- Cryopreserved Human Precision-Cut Lung Slices as a Bioassay for Live Tissue Banking. A Viability Study of Bronchodilation with Bitter-Taste Receptor AgonistsAmerican Journal of Respiratory Cell and Molecular Biology, 2016
- Analysis of drug combinations: current methodological landscapePharmacology Research & Perspectives, 2015
- The Impact of Food Bioactives on Health2015
- Cryopreservation of precision-cut tissue slicesXenobiotica, 2012
- Cryopreservation of precision cut tissue slices (PCTS): Investigation of morphology and reactivityExperimental and Toxicologic Pathology, 2011